We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Supporta | SOR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 30.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 30.50 | 30.50 |
| Top Posts |
|---|
Posted at 23/12/2009 08:03 by remi2059 Another potential investor doing due diligence... sounds good.Phillis- where can you get a copy of the offer doc? Thanks |
Posted at 19/6/2008 06:15 by longshanks OK - John Gannon - Development Director - ex MD of Terraquest.Interesting to see insiders increasing their stake Considering info about the potential offer was not public domain at the time of his purchase - is this not insider dealing? Of course it could be entirely coincidental ;) -------------------- By my estimate...Romac have spent approximately £10.5m buying their 30% stake in SOR for an average price of approx 42p. My guess is that their initial proposal was at a takeover price of 30p...to "safeguard their investment" - giving a value of approx £25m to the business (including their existing £10.5m investment) . A counter offer of 40p by the third party would have been below par value for Romac and hence they rejected it. My guess is that they will up their bid to match the 40p offer. John Gannon in the mean time has been filling his boots - presumably with proceeds from the sale of TerraQuest to SOR. Seeing as he is Development Director - he must be in a key position to see the lie of the land and no doubt has good cause to be optimistic. Looks to me like the price of a recovery is still not factored into the price...let alone the value ascribed to the business by Romac. Figures are imminent that could well underpin such a recovery and give cause for a rerating by institutional investors. |
Posted at 12/11/2006 20:11 by phillis Hi Tonester.Reported CSH to AIM a couple of weeks ago - no longer a holder! Yes have been a holder in SOR since late 04 when I noticed that Peter Webb at Unicorn was an investor. Bought between 44 and 50p. Not sure I like the move away from the social service side but RPS seem to do OK What do you know about BAY? |
Posted at 16/5/2005 11:38 by deehill I do apologise, Gentlemen. I started a new strand for Supporta but would gladly relinquish it in favor of this one.Sir J is right....and this suprises me with all the other Mears Investors in that they seem content to follow Mears but s/b following Holt. If they do, they will find two other companies - Supporta being one of them and Sir J is right when he says that Holt has taken a back seat on this one BUT purely because the current folk running it are more than competent. As I have indicated on the other strand, the firmness of price in SOR is some indication that summats brewing. The other is Wyatt and this one could be even more interesting in that NO LESS THAN THREE Mears Directors appear on its Board. It just has put the drug detection deal under its belt there are indications of other fish to fry. None of the 'smaller Holt's' have really shown their paces, yet but at Mears there is a new CEO in place and, seemningly, he has fitted in right well. Which should leave Mr Holt with some time to devote the other parts of the 'stable' |
Posted at 15/10/2004 08:28 by phillis signs of activity - good to see Peter Webb of Unicorn as the major investor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
